RESUMO
Harnessing the energy of tidal currents has huge potential as a source of clean renewable energy. To do so in a reliable and cost effective way, it is critical to understand the interaction between tidal turbines, waves, and turbulent currents in the ocean. Scaled testing in a tank test provides a controlled, realistic, and highly reproducible down-scaled open ocean environment, and it is a key step in gaining this understanding. Knowledge of the hydrodynamic conditions during tests is critical and measurements at multiple locations are required to accurately characterise spatially varying flow in test tank facilities. The paper presents a laboratory technique using an acoustic velocimetry instrument, the range over-which measurements are acquired being more akin to open water applications. This enables almost simultaneous multi-point measurements of uni-directional velocity along a horizontal profile. Velocity measurements have been obtained from a horizontally mounted Single Beam Acoustic Doppler (SB-ADP) profiler deployed in the FloWave Ocean Energy Research Facility at the University of Edinburgh. These measurements have been statistically compared with point measurements obtained while using a co-located Acoustic Doppler Velocimeter (ADV). Measurements were made with both instruments under flow velocities varying from 0.6 ms-1 to 1.2 ms-1, showing that flow higher than 1 ms-1 was more suitable. Using a SB-ADP has shown the advantage of gaining 54 simultaneous measurement points of uni-directional velocity, covering a significant area with a total distance of 10 m of the test-tank, at a measurement frequency of 16 Hz. Of those measurement points, 41 were compared with co-located ADV measurements covering 8 m of the profile for a tank nominal flow velocity of 0.8 ms-1, and four distributed locations were chosen to to carry out the study at 0.6 ms-1, 1.0 ms-1, and 1.2 ms-1. The comparison with the ADV measurement showed a 2% relative bias on average.
RESUMO
OBJECTIVES: To review changes in patterns of care for women with early invasive breast cancer in Western Australia from 1989 to 1999, and compare management with recommendations in the 1995 National Health and Medical Research Council guidelines. DESIGN AND SETTING: Population-based surveys of all cases listed in the Western Australian Cancer Registry and Western Australian Hospital Morbidity Data System. MAIN OUTCOME MEASURES: Congruence of care with guidelines. RESULTS: Data were available for 1649 women with early invasive breast cancer (categories pT1or pT2; pN0 or pN1; and M0). In 1999, 96% had a preoperative diagnosis by fine-needle aspiration or core biopsy (compared with 66% in 1989), with a synoptic pathology report on 95%. Breast-conserving surgery was used for 66% of women with mammographically detected tumours (v 35% in 1989) and 46% of those with clinically detected tumours (v 28% in 1989), with radiotherapy to the conserved breast in 90% of these cases (83% in 1989). Adjuvant chemotherapy was given to 92% of premenopausal women with node-positive disease and 63% with poor-prognosis node-negative tumours (v 78% and 14%, respectively, in 1989). Among postmenopausal women with receptor-positive tumours, tamoxifen was prescribed for 91% of those with positive nodes (85% in 1989) and 79% of those with negative nodes (30% in 1989). Among postmenopausal women with receptor-negative tumours, chemotherapy was prescribed for 70% with positive nodes (v 33%) and 58% with negative nodes (v none). CONCLUSIONS: Patterns of management of women with early invasive breast cancer in Western Australia during the 1990s changed significantly in all respects toward those recommended in the 1995 guidelines.
